Word on the grapevine is results are due around 3rd week of March.
We are looking at possibly one of the best Arthritis drugs and safest in a massive market, annually around 16 bill per annum.
The market caps of its competitiors are in the billions.
Phase 2 results are the ones we are awaiting and the majority of takeovers occur straight after phase 2 results.
Going on the latest deal in the athritis sector for a similar company at an earlier stage we should be trading at around $2+ at least on a market cap comparison.
1 of 2 things is starting to happen, traders are beginning to get set with only a 3 week wait. Or news is leaking of the results going on the trading action of the last 2 days.
Anyway I think if results are as good as the last set were we could easily see a share price of well over $2 and will even go out on a limb and say $5 is a realistic possibility down the track.
Any other price targets on success of the RA side of things discounting Lupus and Psoriasis welcomed.
Its been a long wait for me and I know some of you guys have been waiting a lot longer than me and have padi substantially more so obviously you think the co is worth more. I would be interested in hearing your targets on success.
CBZ Price at posting:
61.3¢ Sentiment: Buy Disclosure: Held